Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,151.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 12.00 (1.039%)
Market Cap: £798.19m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisition

7 Oct 2008 07:00

RNS Number : 2159F
CVS Group plc
07 October 2008
Β 

ο»Ώ

For ImmediateΒ Release

7 OctoberΒ 2008

CVS Group plc

("CVS" or the "Company")

AcquisitionΒ ofΒ Rossendale Pet CrematoriumΒ Limited

CVS, one of theΒ UK's leading providers of veterinary services, is pleased to announce the acquisition ofΒ Rossendale Pet Crematorium Limited ('the crematorium').

Β 

The acquisition, which includes the freehold property from which the crematorium operates, has been financed wholly from the Company's cash flow,Β continuing to demonstrateΒ the ability of the Company to finance its acquisition pipeline directly from internally generated cash.

Β 

BasedΒ in Lancashire,Β within aΒ thirteen acreΒ site, the crematoriumΒ andΒ MemorialΒ GardensΒ wereΒ established in 1967,Β aiming to provide bereaved pet owners with the best and widest options in coping with the death of their pets.Β 

CVS will assume all management responsibilities for the crematorium following completion of the acquisition including the nine current employees.

In the year endedΒ 31 December 2007,Β theΒ crematoriumΒ achieved an Operating Profit of Β£136,000Β on turnover of Β£490,000Β and had gross assets of Β£503,000.

The acquisition of a crematoriumΒ will be a great enhancement toΒ CVS' existingΒ portfolio of 151Β veterinaryΒ surgeriesΒ andΒ 4Β veterinary laboratories.Β Further broadeningΒ theΒ veterinary servicesΒ offering,Β the acquisition providesΒ a new divisionΒ which, in line with CVS'Β statedΒ strategy,Β will allow the CompanyΒ to continue to generate stronger returns through vertical integration of key suppliers to the veterinary market.

CVS owned practices send minimal levels of work to the crematorium, therefore providing the opportunity for CVS surgeries to cascade work there post completion, where logistically suitable.

Commenting on theΒ acquisition,Β CVS Chief Executive Simon Innes said:Β 

"The acquisition of RossendaleΒ PetΒ Crematorium is an important addition to the CVS group of businessesΒ as well as a natural progression for our Company. In line with all acquisitions to date, it offers aΒ highΒ quality business with dedicated professionals.

The potential forΒ cost synergiesΒ means thatΒ weΒ will enhanceΒ ourΒ shareholder returnsΒ at the same time as improving ourΒ clientΒ offering."

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

Buchanan Communications

Richard Oldworth

Suzanne Brocks

020 7466 5000

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQILFITIVLRIIT
Date   Source Headline
21st May 20199:15 amRNSHolding(s) in Company
20th May 201911:17 amRNSHolding(s) in Company
15th May 20194:09 pmRNSHolding(s) in Company
15th May 20194:09 pmRNSHolding(s) in Company
14th May 201911:28 amRNSHolding(s) in Company
9th May 201910:29 amRNSHolding(s) in Company
7th May 20192:30 pmRNSHolding(s) in Company
1st May 20197:00 amRNSTotal Voting Rights
18th Apr 20194:25 pmRNSHolding(s) in Company
18th Apr 201910:50 amRNSHolding(s) in Company
18th Apr 201910:26 amRNSHolding(s) in Company
16th Apr 20196:05 pmRNSHolding(s) in Company
10th Apr 20195:17 pmRNSHolding(s) in Company
2nd Apr 20199:42 amRNSHolding(s) in Company
29th Mar 20197:00 amRNSInterim Results
26th Mar 20194:14 pmRNSHolding(s) in Company
25th Mar 20196:21 pmRNSHolding(s) in Company
25th Mar 20191:30 pmRNSHolding(s) in Company
1st Mar 20197:00 amRNSTotal Voting Rights
15th Feb 20194:46 pmRNSHolding(s) in Company
15th Feb 20194:45 pmRNSHolding(s) in Company
15th Feb 20194:44 pmRNSHolding(s) in Company
5th Feb 20194:20 pmRNSHolding(s) in Company
5th Feb 20194:20 pmRNSHolding(s) in Company
5th Feb 20194:00 pmRNSHolding(s) in Company
4th Feb 20194:15 pmRNSHolding(s) in Company
1st Feb 20197:00 amRNSTotal Voting Rights
31st Jan 20194:41 pmRNSDirector/PDMR and PCA Shareholding
31st Jan 20198:30 amRNSDirector/PDMR Shareholding
29th Jan 20197:00 amRNSTrading Update
10th Jan 20191:51 pmRNSHolding(s) in Company
19th Dec 20187:00 amRNSBlock Admission
18th Dec 20184:45 pmRNSHolding(s) in Company
14th Dec 20187:00 amRNSExercise of Options and Total Voting Rights
6th Dec 201811:41 amRNSDirector/PDMR and PCA Shareholding
4th Dec 20186:15 pmRNSDirector/PDMR and PCA Shareholding
4th Dec 20189:47 amRNSHolding(s) in Company
3rd Dec 20184:41 pmRNSHolding(s) in Company
3rd Dec 201810:30 amRNSGrant of Options under SAYE Option Scheme and TVR
3rd Dec 201810:06 amRNSHolding(s) in Company
30th Nov 20184:53 pmRNSHolding(s) in Company
29th Nov 20181:48 pmRNSResult of AGM
29th Nov 20187:00 amRNSAnnual General Meeting Trading Update
14th Nov 201811:48 amRNSHolding(s) in Company
12th Nov 20183:56 pmRNSHolding(s) in Company
12th Nov 20183:50 pmRNSHolding(s) in Company
6th Nov 20185:11 pmRNSPosting of Annual Report and Notice of AGM
5th Nov 20188:05 amRNSExercise of Options, Directors' Dealing and TVR
31st Oct 20185:32 pmRNSTotal Voting Rights
24th Oct 201810:43 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.